Sandra Coral
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 01, 2025
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.
Journal: OncoTargets and therapy
Published: March 12, 2025
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 24, 2024
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Journal: Journal of translational medicine
Published: December 22, 2023
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.
Journal: Nature communications
Published: December 22, 2022
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 02, 2022
A novel microRNA signature for the detection of melanoma by liquid biopsy.
Journal: Journal of translational medicine
Published: July 15, 2022
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 23, 2019
Last Updated: 09/26/2026